These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
96 related items for PubMed ID: 1436167
1. [Postmenopausal estrogen replacement therapy and the risk of atherosclerotic cardiovascular diseases]. Donders SH. Ned Tijdschr Geneeskd; 1992 Jul 25; 136(30):1478. PubMed ID: 1436167 [No Abstract] [Full Text] [Related]
15. [Cardiovascular effects of replacement hormones]. Kornitzer M, Hindlet JY. Rev Med Brux; 1995 Sep 05; 16(4):285-90. PubMed ID: 7481244 [Abstract] [Full Text] [Related]
16. [Postmenopausal estrogen substitution and the risk of atherosclerotic heart and vascular diseases]. Dekker E, Büller HR, Kastelein JJ. Ned Tijdschr Geneeskd; 1992 Jun 20; 136(25):1197-200. PubMed ID: 1614566 [No Abstract] [Full Text] [Related]
18. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study. Chang TC, Lien YR, Chen M, Cheng SP, Chen RJ, Chow SN. Acta Obstet Gynecol Scand; 2004 Jul 20; 83(7):661-6. PubMed ID: 15225192 [Abstract] [Full Text] [Related]
19. [Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women]. Imperato F, Marziani R, Perniola G, Ebano V, Fruscella M, Mossa B. Minerva Ginecol; 2003 Feb 20; 55(1):87-93. PubMed ID: 12598849 [Abstract] [Full Text] [Related]
20. [Lipoprotein(a) and the cardiovascular risk during estrogen-progestin replacement therapy in postmenopause]. Porcelli A, Calleri L, Gallello D, Taccani C, Surico N. Minerva Ginecol; 1997 Feb 20; 49(1-2):39-42. PubMed ID: 9162884 [Abstract] [Full Text] [Related] Page: [Next] [New Search]